REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 94 filers reported holding REATA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,120,000 | +260.3% | 20,000 | +233.3% | 2.00% | +146.9% |
| Q1 2020 | $866,000 | -89.0% | 6,000 | -84.5% | 0.81% | -84.9% |
| Q4 2019 | $7,890,000 | +158.6% | 38,600 | +1.6% | 5.36% | +128.8% |
| Q3 2019 | $3,051,000 | -5.9% | 38,000 | +10.6% | 2.34% | +5.0% |
| Q2 2019 | $3,241,000 | +18.5% | 34,350 | +7.3% | 2.23% | +14.1% |
| Q1 2019 | $2,735,000 | +52.4% | 32,000 | 0.0% | 1.96% | +22.5% |
| Q4 2018 | $1,795,000 | -31.4% | 32,000 | 0.0% | 1.60% | -6.7% |
| Q3 2018 | $2,616,000 | +87.0% | 32,000 | -20.0% | 1.71% | +72.7% |
| Q2 2018 | $1,399,000 | – | 40,000 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |